Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 05, 2018 07:00 ET | Source: Verkkokauppa.com Oyj

Verkkokauppa.com Oyj - Managers' Transactions - Häggblom

Verkkokauppa.com Oyj MANAGERS' TRANSACTIONS November 5, 2018 at 14:00 Managers' Transactions Transaction notification under Article 19 of EU Market Abuse Regulation. Person...
November 05, 2018 07:00 ET | Source: Verkkokauppa.com Oyj

Verkkokauppa.com Oyj - Managers' Transactions - Seppälä

Verkkokauppa.com Oyj MANAGERS' TRANSACTIONS November 5, 2018 at 14:00 Managers' Transactions Transaction notification under Article 19 of EU Market Abuse Regulation. Person...
November 05, 2018 07:00 ET | Source: Signify

Signify share repurchase periodic update

Press Release November 5, 2018 Signify share repurchase periodic update Eindhoven, the Netherlands - Signify (Euronext: LIGHT), the world leader in lighting, today announced that it has...
November 05, 2018 07:00 ET | Source: ADVA Optical Networking SE

Oscilloquartz launches ultra-scalable phase and time sync solution for the 5G era

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Modular design, hardware redundancy and...
November 05, 2018 07:00 ET | Source: Vogogo Inc.

Vogogo Announces Debt Conversion

CALGARY, Alberta, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Vogogo Inc. (CSE: VGO) (“Vogogo” or the “Company”) today announced that it signed a settlement and release agreement (“Agreement”) with the vendor...
November 05, 2018 07:00 ET | Source: Clearside Biomedical, Inc.

Clearside Biomedical Announces SAPPHIRE Phase 3 Study of Combination Therapy in Retinal Vein Occlusion Did Not Meet Its Primary Endpoint

- Focusing Resources on Uveitis Program; NDA Filing Expected Fourth Quarter 2018 - - Company to Host Conference Call at 8:30 a.m. ET to Review the 8-Week Topline Data - ALPHARETTA, Ga., Nov. 05,...
November 05, 2018 07:00 ET | Source: Dova Pharmaceuticals, Inc.

Dova Pharmaceuticals Announces FDA Acceptance of Supplemental New Drug Application for DOPTELET® (avatrombopag) for the Treatment of Chronic Immune Thrombocytopenia (ITP)

DURHAM, N.C., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA), a pharmaceutical company focused on acquiring, developing, and commercializing drug candidates for diseases...
November 05, 2018 07:00 ET | Source: Arcturus Therapeutics, Inc.

Arcturus Therapeutics Hosts Ribbon Cutting Ceremony for its Research and Development Facility

SAN DIEGO, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT), a leading RNA medicines company, will officially cut the ribbon on its San Diego based research and...
November 05, 2018 07:00 ET | Source: Abeona Therapeutics Inc.

Abeona Therapeutics and REGENXBIO Announce Worldwide Exclusive Licenses for the Treatment of Four Rare Lysosomal Storage Disorders Using NAV AAV9 Vector

Abeona granted new licenses to NAV AAV9 for the development and commercialization of treatments for MPS IIIA, MPS IIIB, CLN1 and CLN3 Batten Disease Abeona to pay REGENXBIO $20 million upfront, $10...
November 05, 2018 07:00 ET | Source: Kamada Ltd.

Kamada to Announce Third Quarter and Nine Months Ended September 30, 2018 Financial Results and Host Conference Call on November 12

REHOVOT, Israel, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived protein therapeutics company, today announced that it will release financial results for...

1 ...154520 154521 154522 ...326067